Weber David M 4
4 · ABIOMED INC · Filed Apr 4, 2022
Insider Transaction Report
Form 4
ABIOMED INCNASD
Weber David M
Chief Operating Officer
Transactions
- Sale
Common Stock, $.01 par value
2022-03-31$340.00/sh−7,500$2,550,000→ 116,314 total
Holdings
- 8,000
Stock Option (right to buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 6,500
Stock Option (right to buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 15,497(indirect: By Trust)
Common Stock, $.01 par value
- 5,000
Stock Option (right to buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying) - 7,000
Stock Option (right to buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 10,000
Stock Option (right to buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 6,000
Stock Option (right to buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 4,969
Stock Option (right to buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F2]This price represents the sale price of the transactions on the reported date at $340.00. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F4]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F5]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.